"Biopharmaceutics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.
| Descriptor ID |
D001702
|
| MeSH Number(s) |
H01.158.703.003 H02.628.049
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biopharmaceutics".
Below are MeSH descriptors whose meaning is more specific than "Biopharmaceutics".
This graph shows the total number of publications written about "Biopharmaceutics" by people in this website by year, and whether "Biopharmaceutics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Biopharmaceutics" by people in Profiles.
-
The Impact of the COVID-19 Pandemic on the Future of Science Careers. Chem Res Toxicol. 2021 03 15; 34(3):672-674.
-
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients. Palliat Med. 2020 10; 34(9):1235-1240.
-
In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound. Mol Pharm. 2018 04 02; 15(4):1607-1617.
-
PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals. Curr Drug Deliv. 2018; 15(3):331-341.
-
Metabolic pathways and pharmacokinetics of natural medicines with low permeability. Drug Metab Rev. 2017 11; 49(4):464-476.